XML 24 R14.htm IDEA: XBRL DOCUMENT v3.21.2
Employee Benefits
6 Months Ended
Jun. 30, 2021
Employee Benefits [Abstract]  
Employee Benefits
Note 7:
Employee Benefits
 
401(k) Savings Plan
 
The Company has a retirement savings 401(k) plan covering substantially all employees. Employees may contribute up to the maximum legal limit with the Bank matching up to 5% of the employee’s salary. Employer contributions charged to expense for the three months ended June 30, 2021 and 2020 totaled $75,000 and $69,000, respectively. Employer contributions charged to expense for the six months ended June 30, 2021 and 2020 totaled $140,000 and $114,000, respectively.
 
Stock-Based Compensation
 
The Company adopted a nonqualified incentive stock option plan (the “Bank7 Corp. 2018 Equity Incentive Plan”) in September 2018. The Bank7 Corp. 2018 Equity Incentive Plan will terminate in September 2028, if not extended. Compensation expense related to the Plan for the three months ended June 30, 2021 and 2020 totaled $171,000 and $191,000, respectively. Employer contributions charged to expense for the six months ended June 30, 2021 and 2020 totaled $473,000 and $371,000, respectively. There were 689,050 shares available for future grants as of June 30, 2021.
 
The Company grants to employees and directors restricted stock units (RSUs) which vest ratably over either three or five years and stock options which vest ratably over four years.  All RSUs and stock options are granted at the fair value of the common stock at the time of the award. The RSUs are considered fixed awards as the number of shares and fair value are known at the date of grant and the fair value at the grant date is amortized over the vesting and/or service period.
 
The Company uses newly issued shares for granting RSUs and stock options.
 
The following table is a summary of the stock option activity under the Bank7 Corp. 2018 Equity Incentive Plan (dollar amounts in thousands, except per share data):

   
 
 
Options
   
 
Wgtd. Avg. Exercise
Price
   
Wgtd. Avg. Remaining
Contractual Term
   
Aggregate
Intrinsic
Value
 
Six Months Ended June 30, 2021
                       
Outstanding at December 31, 2020
   
185,250
   
$
18.73
             
Options Granted
   
80,500
     
14.31
             
Options Exercised
   
-
     
-
             
Options Forfeited
   
-
     
-
             
Outstanding at June 30, 2021
   
265,750
     
17.39
     
8.08
   
$
243,720
 
Exercisable at June 30, 2021
   
86,307
     
18.75
     
7.37
   
$
3,525
 

The fair value of each option grant is estimated on the date of grant using the Black-Scholes option-pricing model and is based on certain assumptions including risk-free rate of return, dividend yield, stock price volatility and the expected term. The fair value of each option is expensed over its vesting period.

The following table shows the assumptions used for computing stock-based compensation expense under the fair value method on options granted during the period presented:
 
   
Six Months Ended
 
   
June 30, 2021
   
June 30, 2020
 
Risk-free interest rate
   
0.52
%
   
1.71
%
Dividend yield
   
2.89
%
   
2.20
%
Stock price volatility
   
66.67
%
   
41.27
%
Expected term
   
6.41
     
7.51
 
 
The following table summarizes share information about RSUs for the six months ended June 30, 2021:
 
Six Months Ended June 30, 2021
 
Number of
Shares
   
Wgtd. Avg. Grant
Date Fair Value
 
Outstanding at December 31, 2020
   
118,000
   
$
18.09
 
Shares granted
   
25,200
     
14.31
 
Shares vested
   
(7,582
)
   
18.02
 
Shares forfeited
   
-
     
-
 
End of the period balance
   
135,618
   
$
17.39
 
 
As of June 30, 2021, there was approximately $1.9 million of unrecognized compensation expense related to 135,618 unvested RSUs and $756,000 of unrecognized compensation expense related to 265,750 unvested and/or unexercised stock options. The stock option expense is expected to be recognized over a weighted average period of 2.88 years, and the RSU expense is expected to be recognized over a weighted average period of 2.76 years.